Skip 
Navigation Link
Drug Addiction
Resources
Basic InformationLatest News
Health Tip: Medication and Substance Abuse RecoveryBeating Opioid Addiction Can Be Tough, Here's What HelpsComing Soon: A 'Pot Breathalyzer'?U.S. Opioid Deaths Take a Small Dip, as Fentanyl Leaves Deadly MarkOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid Claims'Synthetic Pot' Laced With Rat Poison Lands People in the ERJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisAmerica Has a Huge -- and Very Costly -- Drug HabitAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesLethal Deception: Deaths From Cocaine Laced With Fentanyl on the RiseMany Young Americans Regret Online Posts Made While HighToo Few U.S. Opioid Users Are Getting OD AntidoteDrug Experimentation and Summer a Dangerous DuoMedical Marijuana Won't Help Ease Opioid Crisis: StudyOpioid Epidemic Doubled Number of U.S. Kids Sent to Foster CareKeep Unused Meds Out of the Hands of AddictsFDA Warns Two Kratom Marketers About False ClaimsFatal Opioid ODs Rise as Temperatures FallDrug ODs, Suicides Soaring Among Millennials: ReportLegalizing Medical Pot Won't Ease Opioid Crisis: StudyDrugstores Often Don't Have Opioid Antidote in Stock, Philly Study Shows'Secret Shopper' Study Finds Many Who Need Addiction Treatment Can't Get ItHealth Tip: Naloxone Fast FactsCould CBD Treat Opioid Addiction?Heroin ODs Have Started Declining in Some StatesQuantity, Not Type of Opioid Matters for Post-Op DependencyMore Than 600,000 Opioid Abusers Raising Kids in U.S.Many Drug Abusers Use Family Members to 'Opioid Shop'Poor, Minorities Shortchanged on Opioid Addiction TreatmentsDispensing Opioid Antidote Without a Prescription Might Save LivesFentanyl Becoming a Deadly Accomplice in Cocaine, Meth AbuseNot Just Opioids: Deaths Tied to Cocaine, Meth Are Soaring, TooMany Drivers Testing Positive for Marijuana, Even With Kids in CarFDA Approves 1st Generic Nasal Spray Against Opioid OverdoseAnother Cost of the Opioid Epidemic: Billions of Dollars in Lost TaxesNurse Practitioners Often Restricted From Prescribing Opioid TreatmentsIn Most States, Insurance Won't Cover Addiction TreatmentsOverdose Deaths From Fentanyl Soaring: ReportMany With Opioid Addiction Don't Get Meds That Can HelpVets Who Get Opioids From VA, Medicare at Higher Overdose RiskU.S. Deaths From Suicide, Substance Abuse Reach Record HighOpioid Overdose Deaths Quadruple, Centered in 8 StatesAmong Rich Nations, U.S. Has Highest Rate of Fatal Drug ODsFDA Fell Short in Preventing Fentanyl Abuse Crisis, Report ClaimsMore Car Crashes Tied to Drivers High on OpioidsPoor Whites Bear the Brunt of U.S. Opioid Crisis, Studies FindOpioid Addicts Are Overdosing on Diarrhea DrugMaking OxyContin 'Tamper Proof' Helped Spread Hepatitis COpioid Danger to Newborns Varies By RegionMany Addiction Centers Lack Anti-Opioid Meds: Study
Links
Related Topics

FDA Approves 1st Generic Nasal Spray Against Opioid Overdose

HealthDay News
by -- Robert Preidt
Updated: Apr 19th 2019

new article illustration

FRIDAY, April 19, 2019 (HealthDay News) -- The first generic naloxone nasal spray to treat opioid overdose has received approval from the U.S. Food and Drug Administration.

Teva Pharmaceuticals' lifesaving product is also the first generic naloxone nasal spray approved for use by people without medical training. There was already a brand-name spray (Narcan) for emergency use by untrained people, such as family members and bystanders.

The need is urgent. On average, more than 130 Americans die every day from overdoses of opioids -- including prescription painkillers such as fentanyl, oxycodone (OxyContin), hydrocodone (Vicodin) and morphine, as well as illegal drugs such as heroin or drugs sold as heroin, the FDA said.

"In the wake of the opioid crisis, a number of efforts are underway to make this emergency overdose reversal treatment more readily available and more accessible," said Dr. Douglas Throckmorton, deputy center director for regulatory programs in the FDA's Center for Drug Evaluation and Research.

"In addition to this approval of the first generic naloxone nasal spray, moving forward we will prioritize our review of generic drug applications for naloxone," he added.

When someone overdoses on opioids, breathing may become shallow or stop completely, leading to death if no one intervenes. If administered quickly, naloxone can counter the effects within minutes.

Throckmorton said in an agency news release that the FDA is also helping drugmakers pursue approval of an over-the-counter naloxone product, and "exploring other ways to increase availability of naloxone products intended for use in the community."

The FDA is also considering whether naloxone should be routinely prescribed along with all or some opioid prescriptions in order to reduce the risk of overdose.

"All together, these efforts have the potential to put a vital tool for combating opioid overdose in the hands of those who need it most -- friends and families of opioid users, as well as first responders and community-based organizations," Throckmorton said.

Nearly 400,000 people in the United States died of opioid overdoses between 1999 and 2017, according to the U.S. Centers for Disease Control and Prevention.

"We're committed to working with other federal, state and local officials, as well as health care providers, patients and communities across the country to combat the staggering human and economic toll created by opioid abuse and addiction," Throckmorton said in the news release.

More information

The U.S. National Institute on Drug Abuse has more about the opioid overdose crisis.